A Phase 1/2a study of LON002 in subjects with advanced solid tumours.
Research type
Research Study
Full title
A Phase 1/2a study of LON002 (sublingual artemether spray) in subjects with advanced solid tumours.
IRAS ID
148747
Contact name
Debashis Sarker
Contact email
Sponsor organisation
LondonPharma Ltd.
Eudract number
2013-003606-11
REC name
London - Central Research Ethics Committee
REC reference
14/LO/0638
Date of REC Opinion
2 May 2014
REC opinion
Favourable Opinion